EMWEB

Their core work

EMWEB is a Belgian biotechnology/bioinformatics SME specializing in virus detection, diagnostics, and molecular epidemiology using high-throughput sequencing technologies. Their core expertise lies in applying next-generation sequencing (NGS), metagenomics, and computational analysis to identify, characterize, and trace viral pathogens — first in human infectious disease contexts, then in crop protection. In practical terms, they help consortia answer the question: "what viruses are present, where did they come from, and how are they spreading?" Their toolkit spans wet-lab virus diagnostics, bioinformatics pipelines, and open-source software for viromics analysis.

What they specialise in

How they've shifted over time

In their first H2020 project (2015–2018), EMWEB worked squarely in human health virology — using metagenomics, phylodynamics, and open-source software to discover novel viruses and trace epidemics in clinical and environmental samples. By 2021, their focus had pivoted to plant virology and agricultural crop protection, applying the same sequencing toolkit to tomato and cucurbit viruses while expanding into biocontrol strategies like biopesticides, natural extracts, and parasitoids. The underlying methodological identity — NGS-based virus detection and diagnostics — remained constant, but the application domain shifted from human infectious disease to food security and sustainable agriculture.

EMWEB is moving deeper into agricultural virology and integrated crop protection, making them an increasingly relevant partner for food security and sustainable farming consortia that need molecular diagnostics expertise.

How they like to work

EMWEB participates exclusively as a consortium partner — they have never led an H2020 project as coordinator, which positions them as a specialist contributor rather than a project manager. Their two projects each involved large, multi-country consortia (averaging roughly 15 partners per project), suggesting they are comfortable operating within complex international teams where they deliver a defined technical component. This profile makes them predictable and low-risk to bring into a consortium: they deliver specialist sequencing and diagnostics work without competing for the coordinator role.

EMWEB has built connections with 30 unique consortium partners across 14 countries through just two projects — an unusually broad network for an SME of this size, reflecting the large international consortia they joined. No geographic concentration is evident from available data, suggesting they engage pan-European research networks rather than a regional cluster.

What sets them apart

EMWEB occupies a rare niche as a private SME that bridges human health virology and plant pathology through a shared methodological foundation in NGS and metagenomics — a combination seldom found outside academic institutions. For consortium builders, this means a single partner can cover both virus discovery/diagnostics tasks and connect them to biocontrol application work. As a Belgian SME rather than a university, they tend to bring faster, more applied deliverables to a consortium without the overhead of academic bureaucracy.

Highlights from their portfolio

• VIROGENESIS
  Their largest funded project (€405,500) and the foundation of their sequencing identity — focused on open-source software and epidemic tracing from metagenomic data, a technically ambitious scope for an SME.
• VIRTIGATION
  Demonstrates successful cross-domain pivot from human health to food security, covering an unusually wide range of mitigation tools (vaccines, biopesticides, natural extracts, parasitoids) within a single project.